GCG and Huntington disease: We observed, only in the manifest HD subjects (39.21 ± 4.03 pg/mL) compared to the BLSA control (56.02 ± 5.75 pg/mL), a significant reduction in circulating glucagon levels (Figure 2E, p = 0.045).